schizophrenia

News and resources

Month: May 2023

May 02 2023

FDA Approves Teva/MedinCell’s Antipsychotic Injection For Adult Schizophrenia Patients

by Clinical Editor

No Comments

The FDA has approved Teva Pharmaceuticals Industries Ltd (NYSE: TEVA) and MedinCell’s approved Uzedy (risperidone) extended-release injectable suspension for schizophrenia in adults. Uzedy is the …

May 02 2023

Schizophrenia injection gets FDA approval

by Clinical Editor

No Comments

The FDA has approved UZEDY (risperidone) extended-release injectable suspension for the treatment of schizophrenia in adults.

May 02 2023

First-Ever Identification of Schizophrenia Risk Markers in Newborns via DNA Methylation

by Clinical Editor

No Comments

The ability to predict the risk of developing schizophrenia later in life may allow early detection and intervention. An international research team led by investigators at Virginia Commonwealth Unive …

May 01 2023

FDA signs off on Otsuka and Lundbeck’s longer-acting Abilify – FiercePharma

by Clinical Editor

No Comments

FDA signs off on Otsuka and Lundbeck’s longer-acting Abilify FiercePharma

May 01 2023

NDA Approved for Long-Acting Injectable for Schizophrenia and Bipolar I – Psychiatric Times

by Clinical Editor

No Comments

NDA Approved for Long-Acting Injectable for Schizophrenia and Bipolar I Psychiatric Times

May 01 2023

FDA Approves Otsuka and Lundbeck’s ABILIFY ASIMTUFII® (aripiprazole), the First Once-Every-Two-Months Long … – Business Wire

by Clinical Editor

No Comments

FDA Approves Otsuka and Lundbeck’s ABILIFY ASIMTUFII® (aripiprazole), the First Once-Every-Two-Months Long … Business Wire

May 01 2023

Schizophrenia Identified in 60 Seconds via Visual Fixation – Neuroscience News

by Clinical Editor

No Comments

Schizophrenia Identified in 60 Seconds via Visual Fixation Neuroscience News

May 01 2023

Pentagon doctor claims prescribing transgender drugs to minors can cause psychotic illness to ‘melt away’ – Fox News

by Clinical Editor

No Comments

Pentagon doctor claims prescribing transgender drugs to minors can cause psychotic illness to ‘melt away’ Fox News

May 01 2023

Teva, MedinCell win FDA nod for long-acting schizophrenia therapy

by Clinical Editor

No Comments

The FDA has approved Uzedy, a long-acting formulation of antipsychotic risperidone developed by Teva (TEVA) and MedinCell as a treatment for adults with schizophrenia.

May 01 2023

People with schizophrenia may have abnormal cyclic gene activity in their brain

by Clinical Editor

No Comments

Researchers say the disruption of 12-hour patterns of cyclic gene activity in the brain may be a factor in the development of schizophrenia …